Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Deluca

Showing results (491-500 of 516) with videos related to

Pageof 52
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardizationN Binkley, D Krueger, C S Cowgill, et al.
Transplantation|November 3, 1998
Prolongation of allograft survival by 1,25-dihydroxyvitamin D3D A Hullett, M T Cantorna, C Redaelli, et al.
The New England Journal of Medicine|October 23, 1975
Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin DS W Kooh, D Fraser, H F DeLuca, et al.
Transplantation|November 3, 1998
1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral densityM T Cantorna, D A Hullett, C Redaelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2006
2MD, a new anabolic agent for osteoporosis treatmentL A Plum, L A Fitzpatrick, X Ma, et al.
Endocrinology|March 1, 1994
A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin geneM S Nanes, H Kuno, M B Demay, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1984
Activation and fusion induced by 1 alpha,25-dihydroxyvitamin D3 and their relation in alveolar macrophagesE Abe, Y Shiina, C Miyaura, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1980
Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamideE G Lufkin, D M Wilson, L H Smith, et al.
The New England Journal of Medicine|August 31, 1978
Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjectsJ P Bilezikian, R E Canfield, T P Jacobs, et al.
The American Journal of Clinical Nutrition|May 1, 1991
Serum 25-hydroxyvitamin D concentrations of free-living subjects consuming olestraD Y Jones, K W Miller, B P Koonsvitsky, et al.
Pageof 52

Showing results (491-500 of 516) with videos related to

Sort By:
Pageof 52
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardizationN Binkley, D Krueger, C S Cowgill, et al.
Transplantation|November 3, 1998
Prolongation of allograft survival by 1,25-dihydroxyvitamin D3D A Hullett, M T Cantorna, C Redaelli, et al.
The New England Journal of Medicine|October 23, 1975
Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin DS W Kooh, D Fraser, H F DeLuca, et al.
Transplantation|November 3, 1998
1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral densityM T Cantorna, D A Hullett, C Redaelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2006
2MD, a new anabolic agent for osteoporosis treatmentL A Plum, L A Fitzpatrick, X Ma, et al.
Endocrinology|March 1, 1994
A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin geneM S Nanes, H Kuno, M B Demay, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1984
Activation and fusion induced by 1 alpha,25-dihydroxyvitamin D3 and their relation in alveolar macrophagesE Abe, Y Shiina, C Miyaura, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1980
Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamideE G Lufkin, D M Wilson, L H Smith, et al.
The New England Journal of Medicine|August 31, 1978
Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjectsJ P Bilezikian, R E Canfield, T P Jacobs, et al.
The American Journal of Clinical Nutrition|May 1, 1991
Serum 25-hydroxyvitamin D concentrations of free-living subjects consuming olestraD Y Jones, K W Miller, B P Koonsvitsky, et al.
Pageof 52